Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Open Access
    Datensatz exportieren als...
  • BibTeX
Measuring Circulating Complement Activation Products in Myeloperoxidase– and Proteinase 3–Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
Arthritis & rheumatology (Hoboken, N.J.), 2019-11, Vol.71 (11), p.1894-1903
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
Frontiers in immunology, 2020-01, Vol.10, p.3069-3069
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses
Frontiers in immunology, 2020-11, Vol.11, p.574997
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
Frontiers in immunology, 2022-05, Vol.13, p.859419-859419
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy
Frontiers in immunology, 2021-10, Vol.12, p.738788-738788
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Complement Pathways in Membranous Nephropathy: Complex and Multifactorial
Kidney international reports, 2020-05, Vol.5 (5), p.572-574
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Proteinuria as a Biomarker for COVID-19 Severity
Frontiers in physiology, 2021-03, Vol.12, p.611772-611772
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
Frontiers in medicine, 2021-01, Vol.7, p.603961
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation
Journal of Immunology Research, 2019, Vol.2019, p.1324804-14
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
Kidney international reports, 2021-04, Vol.6 (4), p.1183-1188
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study
Frontiers in medicine, 2021-01, Vol.7, p.608804
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial
Frontiers in medicine, 2020-08, Vol.7, p.412-412
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment
Kidney international, 2020-06, Vol.97 (6), p.1287-1296
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Corrigendum to "Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D and Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment." Kidney Int. 2020;97:1287-1296
Kidney international, 2021-05, Vol.99 (5), p.1244-1244
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults
Kidney international reports, 2021-06, Vol.6 (6), p.1603-1613
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Rituximab bioavailability in primary membranous nephropathy
Nephrology, dialysis, transplantation, 2019-08, Vol.34 (8), p.1423-1425
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy
Clinical journal of the American Society of Nephrology, 2019-03, Vol.14 (3), p.469-481
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous Nephropathy
Clinical journal of the American Society of Nephrology, 2023-06, Vol.18 (6), p.785-787
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Corrigendum to "Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy" Kidney International Reports Volume 6, Issue 4, April 2021, Pages 1183-1188
Kidney international reports, 2024-07, Vol.9 (7), p.2313
2024
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Corrigendum to “Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy” [Kidney International Reports Volume 6, Issue 4, April 2021, Pages 1183-1188]
Kidney international reports, 2024-07, Vol.9 (7), p.2313-2313
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Measuring circulating complement activation products in myeloperoxidase and proteinase 3 antineutrophil cytoplasmic antibody vasculitis
Arthritis & rheumatology (Hoboken, N.J.), 2019-10, Vol.71 (11), p.1894-1903
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Erratum to “Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D, Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment” Kidney Int. 2020;97:1287–1296
Kidney international, 2020-12, Vol.98 (6), p.1621-1621
2020
Volltextzugriff (PDF)
1 – 22 von 22
Suche als RSS-Feed
Suchergebnisse filtern
Filter anzeigen